TLDR Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.
The article discusses a case of a 58-year-old man with ophiasis alopecia areata, a subtype of AA that presents as a band-like hair loss pattern on the occipital, temporal, and parietal regions of the scalp. The patient was treated with clobetasol 0.05% solution and four treatments of microneedling with triamcinolone over 6 months, resulting in gradual improvement, most notably on his left occipital scalp where his hair loss was most prominent, with near complete hair regrowth on his left occipital scalp. Microneedling with triamcinolone can be considered as a promising treatment in cases of ophiasis AA.
191 citations,
May 2018 in “British journal of dermatology/British journal of dermatology, Supplement” Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.
58 citations,
December 2017 in “Journal of The European Academy of Dermatology and Venereology” Microneedling can help stimulate hair growth, especially when used with other treatments, but it's not better than existing therapies.
30 citations,
August 2015 in “JAAD case reports” Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.
19 citations,
June 2015 in “Seminars in Cutaneous Medicine and Surgery” There is no cure for alopecia areata, and treatment success depends on the individual's situation.
6 citations,
May 2012 in “The Journal of Dermatology” Fexofenadine may help treat a difficult type of hair loss.
July 2013 in “DeckerMed Medicine” The document's conclusion cannot be provided because the document is not readable or understandable.
Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.
12 citations,
January 2006 in “Journal of Dermatological Treatment” Topical 1% sildenafil is not recommended for treating alopecia areata in children.
